Myelodysplastic features and cellular senescence in autoimmune disorders: a pilot study on patients with collagen tissue disorders and immune thrombocytopenic purpura
null
Myelodysplastic features and cellular senescence in autoimmune disorders: a pilot study on patients with collagen tissue disorders and immune thrombocytopenic purpura
null
___
- 1. Yetgin S, Özen S, Saatci U, Bakkaloglu A, Besbas N, Kirel B. Myelodysplastic features in juvenile rheumatoid arthritis. Am J Hematol 1997; 54: 166–169.
- 2. Yetgin S, Ozen S, Yenicesu I, Çetin M, Bakkaloğlu A. Myelodysplastic features in polyarteritis nodosa. Pediatr Hematol Oncol 2001; 18: 157–160.
- 3. Olcay L, Yetgin S, Okur H, Erekul S, Tuncer M. Dysplastic changes in idiopathic thrombocytopenic purpura and the effect of corticosteroids to increase dysplasia and cause hyperdiploid macropolycytes. Am J Hematol 2000; 65: 99–104.
- 4. Gorbunova V, Seluanov A, Pereira-Smith OM. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J Biol Chem 2002; 277: 38540–38549.
- 5. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192: 547–556. 6. Miranda EI, Santana C, Rojas E, Hernández S, OstroskyWegman P, García-Carrancá A. Induced mitotic death of HeLa cells by abnormal expression of c-H-ras. Mutat Res 1996; 349: 173–182.
- 7. Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 2007; 397: 84–93.
- 8. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. P Natl Acad Sci USA 1995; 92: 9363– 9367.
- 9. Macieira-Coelho A. Chromatin reorganization during senescence of proliferating cells. Mutat Res 1991; 256: 81–104.
- 10. Adhya AK, Ahluwalia J, Varma N, Das R, Varma S. Abnormal chromatin clumping in leucocytes of Ph positive chronic myeloid leukemia cases - extending the morphological spectrum. Indian J Pathol Microbiol 2008; 51: 548–550.
- 11. Hahn YS, Kim JG. Pathogenesis and clinical manifestations of juvenile rheumatic arthritis. Korean J Pediatr 2010; 53: 921– 930.
- 12. Yap DYH, Lai KN. The role of cytokine in the pathogenesis of systemic lupus erythematosus - from bench to bedside. Nephrology 2013; 18: 243–255.
- 13. Guo XH, Zhao F, Shi W, Ma XM, Xu Q, Patiguli AB, Halida YS. Detection and clinical significance of Th1/Th2 cytokines in patients with idiopathic thrombocytopenic purpura. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2012; 28: 1185–1187 (in Chinese with English abstract).
- 14. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010;16: 238–246.
- 15. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol 2009; 21: 418–424.
- 16. Qi A, Zhou H, Zhou Z, Huang X, Ma L, Wang H, Yang Y, Zhang D, Li H, Ren R, Yang R. Telomerase activity increased and telomere length shortened in peripheral blood cells from patients with immune thrombocytopenia. J Clin Immunol 2013; 33: 577–585.
- 17. Prelog M, Schwarzenbrunner N, Sailer-Höck M, Kern H, Klein-Franke A, Ausserlechner MJ, Koppelstaetter C, Brunner A, Duftner C, Dejaco C et al. Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 2153–2162.